373461004: Prokinetic Agent (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1198760018 Prokinetic Agent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1211933017 Prokinetic Agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

190081000077118 agent procinétique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
agent procinétique	Is a	Gastrointestinal agent (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dexpanthenol agent	Is a	False	agent procinétique	Inferred relationship	Some
Prokinetic Agent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Dexpanthenol	Is a	False	agent procinétique	Inferred relationship	Some
Product containing trimethobenzamide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing cisapride (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Domperidone(motility) [see chapter d for preparations]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Domperidone [nausea]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely domperidone 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely domperidone 1 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely domperidone 30 milligram/1 each conventional release rectal suppository (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide hydrochloride product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide hydrochloride 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
chlorhydrate de métoclopramide 5 mg/mL, ampoule de 2 mL de solution pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide hydrochloride 15mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide hydrochloride 15mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide hydrochloride 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide hydrochloride 1mg/mL pediatric oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
chlorhydrate de métoclopramide 5 mg/mL, fiole de 20 mL pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide hydrochloride 5mg/5mL s/f oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Cisapride 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Cisapride 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing domperidone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing metoclopramide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely trimethobenzamide hydrochloride 250 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely trimethobenzamide hydrochloride 100 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Trimethobenzamide hydrochloride 100 mg/2% suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Trimethobenzamide hydrochloride 200 mg/2% suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Trimethobenzamide hydrochloride 100 mg/mL intramuscular solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Trimethobenzamide hydrochloride 100mg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide hydrochloride 5mg/mL infusion solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Trimethobenzamide hydrochloride 100mg/mL bar	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Cisapride 1mg/mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Trimethobenzamide hydrochloride 100mg suppositories	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Trimethobenzamide hydrochloride 200mg suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Benzocaine + trimethobenzamide hydrochlor 2%ww/100mg suppositories	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing metoclopramide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing benzocaine and trimethobenzamide hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing aspirin and metoclopramide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing metoclopramide and paracetamol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing domperidone maleate and paracetamol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely trimethobenzamide hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing trimethobenzamide hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide (as metoclopramide hydrochloride) 10 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some
Metoclopramide (as metoclopramide hydrochloride) 5 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1198760018	Prokinetic Agent (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1211933017	Prokinetic Agent	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
190081000077118	agent procinétique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module